Clinical Trial Update: A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating ASP2138 given alone or with other cancer therapies in adults with gastric adenocarcinoma, gastroesophageal junction adenocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma
• Pancreatic Adenocarcinoma

Drugs mentioned

• ASP2138 (ASP2138)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma | Phase 1 | Status: RECRUITING